Get notified when CRVO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — The auditor's report includes a going concern explanatory paragraph, indicating substantial doubt about the company's ability to continue operating.
CervoMed prices $10M best-efforts offering of 2.5M shares at $4.00, a premium to last sale
Filed June 22, 2026 · ~1 min read
Key Changes
-
high
CervoMed is offering 2.5M shares at $4.00 each, a premium to the $3.81 last sale, with no minimum and best-efforts placement.
The Offering verify on EDGAR → -
high
The company estimates $9.1M net proceeds, to be used for working capital and general corporate purposes.
Use of Proceeds verify on EDGAR → -
high
New investors face immediate dilution of $1.83 per share, as the offer price exceeds pro forma net tangible book value.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
Partner
Trade CRVO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify